BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 40 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $446,000 | -9.0% | 430,000 | 0.0% | 0.33% | -27.4% |
| Q2 2019 | $490,000 | -2.6% | 430,000 | -2.3% | 0.46% | +43.7% |
| Q1 2019 | $503,000 | -1.9% | 440,000 | -4.3% | 0.32% | -20.3% |
| Q4 2018 | $513,000 | -12.3% | 460,000 | -5.2% | 0.40% | +1.5% |
| Q3 2018 | $585,000 | -9.6% | 485,000 | -11.0% | 0.39% | +12.0% |
| Q2 2018 | $647,000 | +165.2% | 545,000 | +147.7% | 0.35% | +123.6% |
| Q1 2018 | $244,000 | +577.8% | 220,000 | +633.3% | 0.16% | +528.0% |
| Q4 2017 | $36,000 | – | 30,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 5,590,000 | $6,433,196,000 | 1.48% |
| SHENKMAN CAPITAL MANAGEMENT INC | 12,450,000 | $14,458,000 | 1.24% |
| LINDEN ADVISORS LP | 20,760,000 | $24,046,000 | 1.05% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $9,250,000 | 0.72% |
| Man Investments (CH) AG | 900,000 | $1,043,000 | 0.54% |
| Nicholas Investment Partners, LP | 6,600,000 | $7,631,000 | 0.53% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 28,035,000 | $32,497,000 | 0.50% |
| SSI INVESTMENT MANAGEMENT LLC | 2,067,000 | $2,389,000 | 0.23% |
| Calamos Advisors LLC | 23,382,000 | $27,088,000 | 0.19% |
| LOOMIS SAYLES & CO L P | 591,575 | $46,025,000 | 0.12% |